Revolution Medicines (RVMD) director sells 10,020 shares in Rule 10b5-1 tax sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Revolution Medicines director and officer Mark A. Goldsmith reported an open-market sale of 10,020 shares of common stock on June 16, 2026 at a weighted average price of $156.1188 per share. The transaction was executed under a pre-arranged Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy tax withholding obligations from restricted stock unit vesting.
Following this sale, Goldsmith directly holds 267,330 shares of Revolution Medicines common stock, which includes 182,938 restricted stock units and 652 shares acquired under the company’s Employee Stock Purchase Plan. He also has additional indirect holdings through family revocable trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,020 shares ($1,564,310)
Net Sell
4 txns
Insider
GOLDSMITH MARK A
Role
See Remarks
Sold
10,020 shs ($1.56M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,020 | $156.1188 | $1.56M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 267,330 shares (Direct, null);
Common Stock — 594,060 shares (Indirect, Trust)
Footnotes (1)
- Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 182,938 restricted stock units. Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust. Held by Jonathan Goldsmith Revocable Trust. Held by Rebecca Goldsmith Revocable Trust.
Key Figures
Shares sold: 10,020 shares
Weighted average sale price: $156.1188 per share
Direct holdings after transaction: 267,330 shares
+4 more
7 metrics
Shares sold
10,020 shares
Open-market sale on June 16, 2026
Weighted average sale price
$156.1188 per share
Open-market sale on June 16, 2026
Direct holdings after transaction
267,330 shares
Common stock directly held following June 16, 2026 sale
Restricted stock units included
182,938 RSUs
Included in direct holdings after transaction
ESPP shares included
652 shares
Acquired under Employee Stock Purchase Plan on May 31, 2026
Trust holding example
64,424 shares
Indirect common stock holding reported through a trust
Additional trust holding example
594,060 shares
Another indirect common stock holding reported through a trust
Key Terms
Rule 10b5-1, restricted stock units, Employee Stock Purchase Plan, Revocable Living Trust
4 terms
Rule 10b5-1 regulatory
"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
restricted stock units financial
"to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Revocable Living Trust financial
"Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust."
FAQ
What indirect RVMD holdings does Mark A. Goldsmith report through trusts?
The filing lists indirect holdings through revocable trusts, including shares held by the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust, the Jonathan Goldsmith Revocable Trust, and the Rebecca Goldsmith Revocable Trust, reflecting additional exposure held in trust form.
How are restricted stock units reflected in Mark A. Goldsmith’s RVMD holdings?
Goldsmith’s direct holdings include 182,938 restricted stock units. These RSUs represent rights to receive shares of Revolution Medicines common stock in the future, and are counted within the 267,330 directly held shares disclosed after the reported sale transaction.